Comparative Pharmacology
Head-to-head clinical analysis: HEXASCRUB versus READYPREP CHG.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HEXASCRUB versus READYPREP CHG.
HEXASCRUB vs READYPREP CHG
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Antiseptic agent that disrupts microbial cell membranes via surfactant activity, reducing surface tension and denaturing proteins.
Chlorhexidine gluconate disrupts microbial cell membranes, causing leakage of cytoplasmic contents and cell death. Its cationic nature binds to negatively charged bacterial cell walls, providing persistent antimicrobial activity.
1-2 sprays applied topically to wound once daily.
No standard systemic dosing; used as a 4% chlorhexidine gluconate topical antiseptic solution applied once daily to entire body for preoperative skin preparation or for chlorhexidine bathing in infection prevention protocols.
None Documented
None Documented
Terminal elimination half-life: 22-30 hours; clinical context: steady-state achieved after 4-5 days of daily dosing.
60 minutes (terminal) in patients with normal renal function; prolonged in renal impairment.
Renal excretion of unchanged drug: 60-70%; fecal elimination: 20-30%; biliary excretion: <5%.
Renal: ~100% unchanged via glomerular filtration. No biliary or fecal elimination.
Category C
Category C
Antiseptic
Antiseptic